Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 19.64% institutional investors, 16.75% insiders, and 63.61% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.97% of CAPR shares. SPDR® S&P Biotech ETF is the top mutual fund, with 2.97% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Capricor Therapeutics	19.64%	16.75%	63.61%
Sector	Healthcare Stocks	57.43%	9.41%	33.16%
Industry	Biotech Stocks	69.02%	8.92%	22.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.97M	8.97%	$40.94M
Vanguard group	2.28M	6.88%	$31.42M
Farallon capital management	2.25M	6.80%	$31.06M
State street	2.21M	6.67%	$30.48M
Blackrock	1.63M	5.19%	$7.77M
Geode capital management	879.47K	2.66%	$12.14M
Altium capital management lp	714.00K	2.16%	$9.85M
Woodline partners lp	629.93K	1.90%	$8.69M
Goldman sachs group	294.77K	0.89%	$4.07M
Susquehanna group, llp	281.30K	0.85%	$3.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Altium capital management lp	714.00K	2.79%	$9.85M
Superstring capital management lp	55.23K	0.66%	$762.16K
Black diamond financial	277.74K	0.57%	$3.83M
Farallon capital management	2.25M	0.16%	$31.06M
Adar1 capital management	56.12K	0.15%	$774.46K
Ubs oconnor	104.80K	0.11%	$1.45M
Eam investors	38.28K	0.07%	$528.21K
Woodline partners lp	629.93K	0.06%	$8.69M
Maven securities	150.00K	0.05%	$2.07M
Pfm health sciences, lp	54.36K	0.05%	$750.13K

Top Buyers

Holder	Shares	% Assets	Change
Farallon capital management	2.25M	0.16%	2.25M
State street	2.21M	0.00%	1.70M
Blackrock	1.63M	0.00%	1.25M
Blackrock funding, inc. /de	2.97M	0.00%	1.22M
Vanguard group	2.28M	0.00%	700.24K

Top Sellers

Holder	Shares	% Assets	Change
Ikarian capital	-	-	-300.00K
Superstring capital management lp	55.23K	0.66%	-282.12K
Point72 asset management	-	-	-250.20K
Advisor group	6.30K	0.00%	-234.45K
Renaissance	-	-	-137.50K

New Positions

Holder	Shares	% Assets	Change	Value
Farallon capital management	2.25M	0.16%	2.25M	$31.06M
Woodline partners lp	629.93K	0.06%	629.93K	$8.69M
Black diamond financial	277.74K	0.57%	277.74K	$3.83M
Maven securities	150.00K	0.05%	150.00K	$2.07M
Kennedy capital management	144.25K	0.04%	144.25K	$1.99M

Sold Out

Holder	Change
Federated hermes	-68.00
Lazard asset management	-69.00
Capital performance advisors llp	-91.00
Yhb investment advisors	-150.00
Signaturefd	-393.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	40	-57.45%	6,498,502	-22.35%	19	3.07%	32	-42.86%	3	-72.73%
Sep 30, 2024	94	38.24%	8,369,327	30.24%	25	6.02%	56	33.33%	11	-26.67%
Jun 30, 2024	68	7.94%	6,426,234	33.35%	20	8.30%	42	-	15	66.67%
Mar 31, 2024	63	57.50%	4,818,919	20.83%	15	6.59%	42	90.91%	9	12.50%
Dec 31, 2023	40	8.11%	3,988,123	-27.56%	15	3.27%	22	83.33%	8	-27.27%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
SPDR® S&P Biotech ETF	1.35M	2.97%	10.22K
Vanguard Total Stock Mkt Idx Inv	1.19M	2.62%	-
iShares Russell 2000 ETF	956.40K	2.10%	-18.70K
Vanguard Institutional Extnd Mkt Idx Tr	647.84K	1.42%	193.00
iShares Russell 2000 Growth ETF	274.73K	0.60%	-324.00
Fidelity Small Cap Index	261.86K	0.58%	-994.00
State St Russell Sm/Mid Cp® Indx NL Cl C	235.69K	0.52%	-
Fidelity Extended Market Index	232.38K	0.51%	66.05K
Vanguard Russell 2000 ETF	162.50K	0.36%	-10.91K
State St Russell Sm Cap® Indx SL Cl I	131.20K	0.29%	43.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 20, 2024	Nippon Shinyaku Co Ltd	-	Buy	$15.00M
Oct 12, 2023	Musket David B	-	Buy	$1.13K
Oct 10, 2023	COLLIER EARL M JR	-	Buy	$28.30K
Oct 09, 2023	Musket David B	-	Buy	$14.33K
Oct 06, 2023	Auwaerter Paul Gisbert	-	Buy	$14.20K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	-

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 19.64%, followed by 16.75% insiders and 63.61% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 69.02%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.97M shares, 8.97%), Vanguard group (2.28M shares, 6.88%), and Farallon capital management (2.25M shares, 6.80%). Together, they hold 22.65% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.79% of its assets in 714K Capricor Therapeutics shares, valued at 9.85M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Capricor Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.35M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools